Oncologic Drugs Advisory Committee
December 17-18, 2002
73rd Meeting
Consultants (voting):
For Bexxar:
James Donald Bridges, M.D.
Medical Director
Maryland Regional Cancer Care Rockville
40 West Gude Drive, Suite #120
Rockville, Maryland 20850
James E. Krook, M.D.
Principal Investigator
Duluth CCOP
400 East Third Street
Duluth, Minnesota 55805
For Casodex:
Peter C. Albertsen, M.D.
University of Connecticut Health Center
Chief, Division of Urology, MC 3955
263 Farmington Ave.
Farmington, Connecticut 06030
Phillip M. Hanno, M.D.
Hospital of the University of Pennsylvania
Urology Division, 3400 Spruce St.
1 Rhoads Pavilion
Philadelphia, Pennsylvania 19104
Alexander Krist, M.D.
3650 Joseph Siewick Drive
Suite 400
Fairfax, Virginia 22033
Mark P. Schoenberg, M.D.
Brady Urological Institute
Johns Hopkins Hospital
600 N. Wolfe St., Marburg 145
Baltimore, Maryland 21287
Patient Representatives (voting):
For Bexxar: Susan Krivacic – Austin, Texas
For Casodex: James Anderson – La Plata, Maryland
Consultant (non-voting):
For Casodex:
David Hoberman, Ph.D.
2236 40th Street N.W. #1
Washington, DC 20007
Industry Representative (non-voting)
George H. Ohye
3 Heritage Hills Court
Skillman, New Jersey 08558-2340